Navigation Links
Exploring the Frontiers of Neuroscience
Date:5/5/2008

Fibromyalgia and Sleep Disorders Scientific Conference

SALEM, Ore., May 5 /PRNewswire/ -- The National Fibromyalgia Research Association (NFRA) will present the Fibromyalgia and Sleep Disorders scientific conference October 2-4, 2008 in Portland, Oregon at the Portland Marriott Downtown Waterfront.

"Clinical and research studies highlight the importance of unrefreshing sleep, fatigue and widespread pain as core problems in patients with fibromyalgia and related illnesses. This meeting, organized by the National Fibromyalgia Research Association (NFRA), will serve as the first major scientific and public meeting to highlight our current understanding of such problems and advances in their treatment," said Harvey Moldofsky, MD.

Fibromyalgia and Sleep Disorders is targeted towards primary care physicians, rheumatologists, nurses, and other clinicians treating chronic pain and sleep disorders. The conference offers 15+ CE/CME hours to physicians and allied healthcare professionals.

"The association of sleep dysfunction with fibromyalgia by Dr. Harvey Moldofsky in the mid-1970s was largely responsible for the subsequent systematic study of fibromyalgia. Over the last quarter century this research has led to the contemporary paradigm of fibromyalgia as being a disorder associated with maladaptive functioning of the central nervous system. We've learned much about sleep, pain, stress, and fatigue pathways. This conference provides a tremendous opportunity for practitioners to review what has been discovered and learn how to apply the information to improve the quality of life for their fibromyalgia patients," said Robert M. Bennett, MD.

An international faculty including Moldfosky and Bennett, as well as other noted fibromyalgia and sleep researchers and clinicians including I. Jon Russell, MD, PhD, George Chrousos, MD, Jerome Siegel, PhD, and Manuel Martinez-Lavin, MD will present an expansive 2-day curriculum. The course offerings will include the interaction of sleep, pain, and mood; the pathophysiology of sleep as related to fibromyalgia; polysomnography; maladaptive brain plasticity in fibromyalgia, and sleep and the autonomic nervous system. The full conference agenda can be found on http://www.nfra.net.

Shanda Shribbs, Executive Director of the NFRA affirmed, "fibromyalgia has been as frustrating for physicians as it is for patients. Tremendous research efforts have led to many more alternatives for gaining control of this chronic illness. The Fibromyalgia and Sleep Disorders scientific conference is a good way for practitioners to learn new options. Attendees will leave the conference with renewed enthusiasm, the tools to provide better treatment for their fibromyalgia patients, and the belief that they can help their patients attain a better quality of life."

The scientific conference will provide opportunities for commercial support such as exhibits, and satellite symposia. Additionally, a Call-for-Abstracts was issued last month.

Organizations, corporations, and media interested in partnership or sponsorship opportunities are asked to contact Shanda Shribbs at Shanda@nfra.net. Registration is through NFRA's website, http://www.nfra.net. Fibromyalgia and Sleep is jointly sponsored by the Postgraduate Institute for Medicine, the National Fibromyalgia Research Association, and Medical Education Trust.

About NFRA

The National Fibromyalgia Research Association (NFRA) is dedicated to furthering physician education and finding a cure for fibromyalgia. NFRA has consistently built on this premise in an effort to raise public, medical, and governmental awareness. NFRA was founded in 1992 by Jack Scott, and has funded $1.6 million dollars towards these goals. Visit http://www.nfra.net for more information.


'/>"/>
SOURCE The National Fibromyalgia Research Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NIH grant supports UCSF research exploring early HIV infection
2. Exploring the Use of Techniques From Neuroscience in Todays Marketing
3. Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression
4. Exploring the Aaah ... $1 Million Grant Advances Aquatic Health Research
5. BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards
6. ATS Medical Announces First Frontiers in Cryoablation Symposium
7. Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
8. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
9. ABR-Affinity BioReagents Announces Its Continued Support for the Society for Neuroscience Annual Meeting in San Diego, November 3 - 7, 2007
10. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
11. News Tips from the Journal of Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Public outrage over ... pollutants have fallen on deaf ears, leaving the water industry itself to research, develop ... stays ahead of the curve in the field of natural alkaline water ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone void ... first in the U.S. to incorporate magnesium, a critical property for bone health ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Ron Norman, CEO ... today the importance of making a distinct rather than generic impression in the job ... to look through a stack of resumes knows that the first impression they give ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... positively linked to the Certified Emergency Nurse (CEN®) certification according to ... (BCEN). The value of certification study, conducted by the Human Resources Research Organization ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... 2017 Sapheneia and Scannerside received FDA 510(k) ... is a third-party Vendor neutral CT product that makes ... compliance with current MITA standards. ... solution is specifically designed to provide CT operators, prior ... doses over a predefined threshold. Scannerside Dose Check is ...
(Date:9/5/2017)...  Getinge, a leading global provider of innovative ... program -- "Color for the Kids!" -- to ... by The Children,s Heart Foundation. Pediatric patients and ... encouraged to download a coloring picture at ... the gallery on the website. For each artwork ...
Breaking Medicine Technology: